Potent antitumor effects of a novel actinomycin D analog Leu5AMD

Cancer Letters

Volumn 268, Issue 1, 2008, Pages 38-45

  Wang, Kai rong ^a,b   Zhang, Bang zhi ^a,b   Zhang, Wei ^a   Yan, Jie xi ^a   Li, Xinlei ^a   Wang, Rui ^a,b  

^a Institute of Biochemistry and Molecular Biology   (China)

^b HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

Author keywords

Actinomycin D; Analog; Antitumor; Apoptosis; SGC 7901 cell

Indexed keywords

DACTINOMYCIN; FLUORESCEIN ISOTHIOCYANATE; LEUCINE ACTINOMYCIN D; LIPOCORTIN 5; PROTEIN BCL 2;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG STRUCTURE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LD 50; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARCOMA; STATISTICAL ANALYSIS; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; DACTINOMYCIN; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; PROTO-ONCOGENE PROTEINS C-BCL-2; SARCOMA 180; STOMACH NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS;

EID: 48349108809     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.03.026     Document Type: Article

References (25)

1. Waring M.J. DNA modification and cancer. Annu. Rev. Biochem. 50 (1981) 159-192
2. Goldberg I.H., Beerman T.A., and Poon R. Antibiotics: nucleic acids as targets in chemotherapy. In: Becker F.F. (Ed). Cancer: A Comprehensive Treatise (1977), Plenum Publishing Corp., New York 427-456
3. Farber S. Chemotherapy in the treatment of leukemia and Wilms' tumor. JAMA 198 (1966) 826-836
4. Lewis J.L. Chemotherapy of gestational choriocarcinoma. Cancer 30 (1972) 1517-1530
5. Wadkins R.M., Jares-Erijman E.A., Klement R., Rudiger A., and Jovin T.M. Actinomycin D binding to single-stranded DNA: sequence specificity and hemi-intercalation model from fluorescence and 1H NMR spectroscopy. J. Mol. Biol. 262 (1996) 53-68
6. In: Meienhofer J., Atherton E., and Perlman D. (Eds). Structure-Activity Relationships Among the Semisynthetic Antibiotics (1977), Academic Press, New York 427-529
7. Katz E., Lloyd H.A., and Mauger A.B. Enzymatic synthesis of actinomycin D and analogues containing N-methylalanine from synthetic pentapeptide lactone precursors. J. Antibiot. (Tokyo) 43 (1990) 731-733
8. Mauger A.B., Stuart O.A., and Katz E. Synthesis and properties of some peptide analogs of actinomycin D. J. Med. Chem. 34 (1991) 1297-1301
9. Ries L.A., Eisner M.P., Kosary C.L., et al. SEER Cancer Statistics Review (2000), National Cancer Institute, Bethesda, MD, USA
10. Hansson L.E., Sparen P., and Nyren O. Survival in stomach cancer is improving: results of a nationwide population-bases Swedish study. Ann. Surg. 230 (1999) 162-169
11. Yu W., Whang I., Suh I., Averbach A., Chang D., and Sugarbaker P.H. Prospective randomized trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer. Ann. Surg. 228 (1998) 347-354
12. Martin S.J., Reutelingsperger C.P., McGahon A.J., Rader J.A., van Schie R.C., LaFace D.M., and Green D.R. Earlier distribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition of overexpression of Bcl-2 and Abl. J. Exp. Med. 182 (1995) 1545-1556
13. Jirí K., and Vachek J. A comparison of the efficacy of pyridostigmine alone and the combination of pyridostigmine with anticholinergic drugs as pharmacological pretreatment of tabun-poisoned rats and mice. Toxicology 177 (2002) 179-185
14. Desjardins L.M., and Macmanus J.P. An adherent cell model to study different stages of apoptosis. Exp. Cell Res. 216 (1995) 380-387
15. Koopman G., Reutelingsperger C., Kuijten G., Keehnen R., Pals S., and Van O.M. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84 (1994) 1415-1420
16. Kroemer G., and Reed J.C. Mitochondrial control of cell death. Nat. Med. 6 (2000) 513-519
17. Kroemer G., Zamzami N., and Susin S.A. Mitochondrial control of apoptosis. Immunol. Today 18 (1997) 44-51
18. Ly J.D., Grubb D.R., and Lawen A. The mitochondrial membrane potential (deltapsi (m)) in apoptosis. Apoptosis 8 (2003) 115-128
19. Johnson L.V., Walsh M.L., and Chen L.B. Localization of mitochondria in living cells with rhodamine 123. Proc. Natl. Acad. Sci. USA 77 (1980) 990-994
20. Nadakavukaren K.K., Nadakavukaren J.J., and Chen L.B. Increased Rhodamine 123 Uptake by carcinoma cells. Cancer Res. 45 (1985) 6093-6399
21. Bernal S.D., Lampidis T.J., Summerhayes I.C., and Chen L.B. Rhodamine-123 selectively reduces clonal growth of carcinoma cells in vitro. Science (1982) 1117-1119
22. Susin S.A., Lorenzo H.K., Zamzami N., Marzo I., Brenner C., Larochette N., Prevost M.C., Alzari P.M., and Kroemer G. Mitochondrial release of caspase-2 and -9 during the apoptotic process. J. Exp. Med. 189 (1999) 381-393
23. Krajewski S., Tanaka S., Takayama S., Schibler M.J., Fenton W., and Reed J.C. Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res. 53 (1993) 4701-4714
24. Li P., Nijhawan D., Budihardjo I., Srinivasula S.M., Ahmad M., Alnemri E.S., and Wang X.D. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91 (1997) 479-489
25. Goldberg I.H., and Friedman P.A. Annu. Rev. Biochem. 40 (1971) 775-810